Mr. Speaker, we are drilling down to the source of the problem tonight.
We are talking about a problem for ORs, ICUs and emergency departments. That is just the tip of the iceberg, because there will be more shortages of common drugs that people are trying to buy.
Many seniors depend on generic drugs. Many provinces buy generic drugs because of the cost issues. Many generic companies do not wish to make low-cost generic drugs mainly because they do not make a profit, or so we are told.
What will happen when the global supply of generic drugs begins to deplete itself? How will we find substitute drugs for patients, whether they are in an ICU, emergency or whether it is a parent whose child needs asthma medication? How will we deal with that problem? That is the root of the problem.